Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in Gemcitabine-Refractory Pancreatic Cancer
NCT00691054Phase 2Completed
- Sponsor
- University of Miami
- Start
- Jun 2008
- Primary completion
- Dec 2012
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel in pancreatic cancer (PC), sponsored by University of Miami. Primary endpoint: Overall Survival Rate at 6 Months. Started Jun 2008; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00691054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691054.